EDITORIAL
Published on 03 Jul 2017
Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response
doi 10.3389/fneur.2017.00311
- 1,143 views
- Frontiers in Neurology
- Neuro-Oncology and Neurosurgical Oncology
- Research Topics
- Pitfalls in the Neuroimaging of Malignant Glioma in the Era of Antiangiogenic and Immuno/Targeted Therapy - Detecting Illusive Disease, Defining Response.
Pitfalls in the Neuroimaging of Malignant Glioma in the Era of Antiangiogenic and Immuno/Targeted Therapy - Detecting Illusive Disease, Defining Response.
5,820
Total downloads
25k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 02 Aug 2016
Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma
doi 10.3389/fneur.2016.00121
- 2,620 views
PERSPECTIVE
Published on 28 Jul 2016
Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
doi 10.3389/fneur.2016.00120
- 4,039 views
- 38 citations
OPINION
Published on 24 Apr 2015
Follow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the Future
doi 10.3389/fneur.2015.00074
- 2,704 views
- 1 citation
REVIEW
Published on 23 Feb 2015
Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response
doi 10.3389/fneur.2015.00033
- 18,348 views
- 144 citations
Published in
Frontiers in Neurology
- Neuro-Oncology and Neurosurgical Oncology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 25kTopic views
- 17kArticle views
- 5,820Article downloads